Secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves overall survival in ...
Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer. Among patients with platinum-sensitive peritoneal ...
ABBOTT PARK, Ill., May 16, 2023 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback